PacBio Announces Second Quarter 2024 Financial Results
07 août 2024 16h05 HE
|
PacBio
MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. Second quarter results: Revenue of $36.0 million...
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
05 août 2024 16h05 HE
|
PacBio
SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore...
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
23 juil. 2024 09h05 HE
|
PacBio
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its...
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
15 juil. 2024 16h03 HE
|
PacBio
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on...
PacBio Grants Equity Incentive Award to New Employee
27 juin 2022 20h00 HE
|
PacBio
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
08 mai 2022 19h00 HE
|
PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
パックバイオ (PacBio)、iLACおよびロボティック･バイオロジー･インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
08 mai 2022 19h00 HE
|
Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質･高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック･バイオロジー･インスティテュート株式会社 (Robotic...
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
05 mai 2022 16h10 HE
|
PacBio
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s...
PacBio Announces First Quarter 2022 Financial Results
04 mai 2022 16h03 HE
|
PacBio
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a...
PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease
21 avr. 2022 09h10 HE
|
PacBio
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research...